Evidence map›Paper›PMID 41973673›Full record

ArticlePLOS global public health2026

Knowledge, acceptability, and attitudes regarding minimally invasive tissue sampling (MITS) techniques in Brazil.

Livia Mendes Almeida, Deborah Nunes Melo, Pedro Mansueto Melo de Souza, Tania Mara Silva Coelho, Anacelia Gomes de Matos Mota, Juliana Costa de Abreu Leite, Barbara Feitosa Leite, Mariana Mendonça Quezado, Beatriz Santos de Castro Gadelha, Fernando Barroso Duarte Filho and 8 more

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Livia Mendes AlmeidaFaculdade de Medicina, Universidade Christus, Brasil.
Deborah Nunes MeloServiço de Verificação de Óbitos Dr Rocha Furtado, Secretaria de Saúde do Ceará, Brasil.ORCID https://orcid.org/0000-0002-7950-0424
Pedro Mansueto Melo de SouzaServiço de Verificação de Óbitos Dr Rocha Furtado, Secretaria de Saúde do Ceará, Brasil.
Tania Mara Silva CoelhoSecretaria de Saúde do Estado do Ceará, Brasil.
Anacelia Gomes de Matos MotaPrograma de Pós-graduação em Patologia, Universidade Federal do Ceará, Brasil.
Juliana Costa de Abreu LeitePrograma de Pós-graduação em Patologia, Universidade Federal do Ceará, Brasil.
Barbara Feitosa LeiteFaculdade de Medicina, Universidade Christus, Brasil.
Mariana Mendonça QuezadoFaculdade de Medicina, Universidade Christus, Brasil.
Beatriz Santos de Castro GadelhaFaculdade de Medicina, Universidade Christus, Brasil.
Fernando Barroso Duarte FilhoFaculdade de Medicina, Universidade Christus, Brasil.
Jesamar Correia Matos FilhoFaculdade de Medicina, Universidade Christus, Brasil.
Beatriz Oliveira CaetanoFaculdade de Medicina, Universidade Christus, Brasil.
Marina Marques MaiaFaculdade de Medicina, Universidade Christus, Brasil.
Ana Teresa Morais MartinsFaculdade de Medicina, Universidade Christus, Brasil.
Rogier van DoornOxford University Clinical Research Unit, Hanoi and Ho Chi Minh City, Vietnam.
Jennifer Ilo Van NuilOxford University Clinical Research Unit, Hanoi and Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0000-0002-5167-5505
Ngan Ta Thi DieuOxford University Clinical Research Unit, Hanoi and Ho Chi Minh City, Vietnam.
Luciano Pamplona de Góes CavalcantiFaculdade de Medicina, Universidade Christus, Brasil.ORCID https://orcid.org/0000-0002-3440-1182

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determining cause of death is fundamental for health services to guide the formulation of appropriate public policies to reduce and prevent mortality. In Brazil, some deaths still do not have their underlying cause defined, and in these cases, performing a complete diagnostic autopsy (CDA) is essential. However, there are challenges that hinder its performance, and in this scenario, minimally invasive tissue sampling (MITS) could be a promising alternative. Here, we explored the knowledge, acceptability, and attitudes towards CDA and MITS in Northeast Brazil. We conducted a cross-sectional study using structured questionnaires that were disseminated using snowball sampling through medical societies networks, social networks, instant messaging groups, and email. Chi-square tests or Fisher's exact tests were performed, as appropriate, to determine the difference between the five groups (i.e., pathologists, non-pathologist physicians, other health professionals, medical students, and the general population). 1,519 individuals participated, predominantly female (67.9%) with a median age of 41 (range 21 - 83) years. There was widespread recognition of the importance of CDA (79.6%) and a predisposition to authorize it among family members (67.0%). 1.5% reported knowing about MITS, and 83.4% believed that greater publicity for MITS would increase accessibility. Among physicians and pathologists (n = 141), 52.2% agreed that trained professionals could perform the technique, and 79.3% agreed that MITS had a lower cost and required less hands-on time than CDA. Regarding implementation, blood (52.2%) and liver (26.1%) were identified as the easiest organs to sample, while brain (50.0%) and spleen (24.0%) were considered the most technically difficult. Although widely accepted among scholars in the field, MITS is little known outside of this environment. Investments in training, standardization of protocols for consent and conduct, and communication strategies that are sensitive to the sociocultural context are fundamental for its adoption as a complementary tool in determining the cause of death in countries like Brazil.

Identifiers

PMID41973673
PMCPMC13075663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.